In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.
Vito Baraka;
Halidou Tinto;
Innocent Valea;
Robert Fitzhenry;
Christopher Delgado-Ratto;
Martin K Mbonye;
Chantal Van Overmeir;
Anna Rosanas-Urgell;
Jean-Pierre Van Geertruyden;
Umberto D'Alessandro 
;
+1 more...
Annette Erhart ;
(2014)
In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.
Antimicrobial agents and chemotherapy, 59 (1).
pp. 734-737.
ISSN 0066-4804
DOI: 10.1128/AAC.03647-14
;
+1 more...
Annette Erhart ;
(2014)
In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.
Antimicrobial agents and chemotherapy, 59 (1).
pp. 734-737.
ISSN 0066-4804
DOI: 10.1128/AAC.03647-14
Plasmodium falciparum Pfcrt-76 and Pfmdr1-86 gene polymorphisms were determined during a clinical trial in Burkina Faso comparing the efficacies of dihydroartemisinin-piperaquine (DHA-PPQ) and artemether-lumefantrine (AL). Significant selection of Pfcrt-K76 was observed after exposure to AL and DHA-PPQ, as well as selection of Pfmdr1-N86 after AL but not DHA-PPQ treatment, suggesting reverse selection on the Pfcrt gene by PPQ. These results support the rational use of DHA-PPQ in settings where chloroquine (CQ) resistance is high.
Full text not available from this repository.
Downloads